Aurobindo Pharma Ltd. — Major Shareholding Notification 2021

Apr 8, 2021

Date: April 6, 2021

To	To
Listing Department,	The Corporate Relations Department
NATIONAL STOCK EXCHANGE OF INDIA LIMITED	BSE LIMITED
Exchange Plaza,	Phiroz Jeejeebhoy Towers,
Sandra Kurla Complex, Sandra (E),	25th floor, Dalal Street,
MUMBAI ·400 051	MUMBAI ·400 001
Company Code No. AUROPHARMA	Company Code No. 524804

Dear Sirs,

Sub: Reporting in terms of Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Pursuant to Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, the disclosure of the promoters' shareholding in Aurobindo Pharma Limited as on 31 st March, 2021 is enclosed.

Pursuant to the applicable provisions of Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, I, K. Nithyananda Reddy, one of the Promoters of the Company and on behalf of the other promoter and Promoter Group of the Company hereby declare that we have not made any encumbrance, directly or indirectly, on the shares held by us in Aurobindo Pharma Limited, other than those already disclosed to the Stock Exchanges during the financial year ended on 31 st March, 2021.

Please take the information on record.

Thanking you,

Yours faithfully,

\1.. . , - ,4 7"

., K. NITHYANANDA REDDY AUTHORISED SIGNATORY (PROMOTRS & PROMOTER GROUP-AUROBINDO PHARMA LIMITED) Plot No. 11, 8-2-269/N/11 Road No.2 Banjara Hills, Navodaya colony Hyderabad - 500034

Disclosures under Reg ulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

	D e t'l al s 0 f Sh are hid0 Ina 'PART --A
1	Name of the Target Company (TC)	AUROBINDO PHARMA LIMITED
2	Names of the Stock Exchange(s) where the shares of	National Stock Exchange of India Limited
	TC are listed	BSE Limited
3	Particulars of the Shareholder(s):
a	Name of person(s) together with Persons Acting in	Promoters:
	Concert (PAC) whose total holding (including that in		1) Mr. P.V. Ram Prasad Reddy
	the form of shares, warrants, convertible securities and		2) Mr. K. Nithyananda Reddy
	any other instrument that would entitle the holder to	Promoter Grou~:
	receive shares in the TC) is more than 25% of the		3) RPR Sons Advisors Pvt.Ltd.
	voting rights of the TC.	Mrs. P. Suneela Rani
		(Jointly holding) (*)
	Or	4) Mrs. K. Rajeswari
		5) Mrs. K. Kirthi Reddy
		6) Mrs. K. Spoorthi
B	Name(s) of promoter(s), member of the promoter	7) Mrs.P.Neha Reddy
	group and PAC with him	8) Mr. K. Prasad Reddy
			9) Mr. K. Surya Prakash Reddy
		10) Dr.M. Sivakumaran
		11) Axis Clinicals Limited
			Trident Chemphar Ltd
			RPR Sons Advisors Pvt. Ltd.
		(Jointly holding) (**)
			12) Mr. M. Sumanth Kumar Reddy
		13) Axis Clinicals Limited
		14) Trident Chemphar Ltd
	(*) Shares held on behalf of RPR Enterprises, a registered partnership firm
	(**) Shares held on behalf of Auryn Labs, a registered partnership firm.
4	Particulars of the shareholding of person(s) mentioned	Number of	% w.r.t total	% w.r.t total
	at (3) above	shares	shares! voting	diluted share!
			capital wherever	voting capital of
			applicable	the TC (*)
	As of 31st March, 2021, holding of
1	Mr. P.V. Ram Prasad Reddy
	a) Shares	18,000,000	3.072	3.072
	b) Voting Rights (otherwise than by shares)	---	---	---
	c) Warrants	--.	--	---
	d) Convertible Securities	---		---
	e) Any other instrument that would entitle the holder to	--	--	---
	receive shares in the TC
	Total	18,000,000	3.072	3.072
2	Mr. K. Nithvananda Reddy
	a) Shares	2,53,59,572	4.328	4.328
	b) Voting Rights (otherwise than by shares)	---	-	---
	c) Warrants	--	---	-
	d) Convertible Securities	--	---	---
	e) Any other instrument that would entitle the holder to	---	-	-
	receive shares in the TC
	Total	2,53,59,572	4.328	4.328

3	RPR Sons Advisors Pvt. Ltd.Mrs.P.Suneela Rani
	(Jointly holding)a) Shares	19,63,76,250	33,515	33,515
	b) Voting Rights (otherwise than by shares)	---	--.-	--.-
			--
	c) Warrants	---	-	----.-.-
	d) Convertible Securitiese) Any other instrument that would entitle the holder toreceive shares in the TC	----	--	--
	Total	19,63,76,250	33,515	33,515
4	Mrs. K. Rajeswari
	a) Shares	18,25,500	0,312	0,312
	b) Voting Rights (otherwise than by shares)		--	--
	c) Warrants	---	---
	d) Convertible Securities	---	-	------
	e) Any other instrument that would entitle the holder toreceive shares in the TC	------	--	--
	Total	18,25,500	0.312	0,312
5	Mrs. K. Kirthi Reddy
	a) Shares	2,04,50,000	3.490	3.490
	b) Voting Rights (otherwise than by shares)		--
	c) Warrants	---		---
	d) Convertible Securities	---	---	---
		---	-----	---
	e) Any other instrument that would entitle the holder toreceive shares in the TC	---		---
	Total	2,04,50,000	3.490	3.490
6	Mrs. K. Spoorthi
	a) Shares	76,00,000	1,297	1,297
	b) Voting Rights (otherwise than by shares)	_	---	---
	c} Warrants	---	--	--
	d) Convertible Securities	--	---	---
	e) Any other instrument that would entitle the holder toreceive shares in the TC	---	---	--
	Total	76,00,000	1,297	1,297
7	Mrs. P. Neha Reddy
	a) Shares	1,30,000	0,022	0,022
	b) Voting Rights (otherwise than by shares)	--	---	---
	c) Warrants	--	---	---
	d) Convertible Securities	-	---	--
	e) Any other instrument that would entitle the holder toreceive shares in the TC	--	-.--	_-
	Total	1,30,000	0,022	0,022

8	Mr. K. Prasad Reddy
	a) Shares	3,01,156	0.051	0.051
	b} Votin[ Rights _(otherwise than by shares)	--	---	---
	c) Warrants	---	---	---
	d) Convertible Securities	-	--	---
	e) Any other instrument that would entitle the holder toreceive shares in the TC	-	---	---
	Total	3,01 ,156	0.051	0.051
9	Mr. K. Surya Prakash Reddy
	a) Shares	7,380	0.001	0.001
	b) Voting Rights (otherwise than by shares)	--	---	---
	c) Warrants	---	---	-
	d) Convertible Securities	-	--	---
	e) Any other instrument that would entitle the holder toreceive shares in the TC	---	--	--
	Total	7,380	0.001	0.001
10	Dr. M. Sivakumaran
	a) Shares	1,44,91,360	2.473	2.473
	b) Voting Rights (otherwise than by shares)	--	---	---
	c) Warrants	---	---	---
	d) Convertible Securities	---	---	--
	e) Any other instrument that would entitle the holder toreceive shares in the TC	--	--	--
	Total	1,44,91,360	2.473	2.473
11	Axis Clinicals LimitedTrident Chemphar LtdRPR Sons Advisors Pvt.Ltd.Jointl ~ holding)
	a) Shares	1,67,26,716	2.855	2.855
	b) Voting Rights (otherwise than by shares)	---	---	--
	c) Warrants	--	--	--
	d) Convertible Securities	---	---	---
	e) Any other instrument that would entitle the holder toreceive shares in the TC	--	--	---
	Total	1,67,26,716	2.855	2.855
12	Mr. M. Sumanth Kumar Reddy
	a) Shares	16,00,000	0.273	0.273
	b) Voting Rights (otherwise than by shares)	---	---	---
	c) Warrants	---	--	--
	d) Convertible Securities	---	--	---
	e) Any other instrument that would entitle the holder toreceive shares in the TC	--	---	-
	Total	16,00,000	0.273	0.273

13	Axis Clinicals Limited
	a) Shares	6,58,000	0.112	0.112
	b) Voting Rights (otherwise than by shares)	---	---	--.-
	c) Warrants	---	---	---
	d) Convertible Securities	---	--	--
	e) Any other instrument that would entitle the holder toreceive shares in the TC	--	---	---
	Total	6,58,000	0.112	0.112
14	Trident Chemphar Limited
	a) Shares	7,89,537	0.135	0.135
	b) Voting Rights (otherwise than by shares)	--	---	---
	c) Warrants	-	---	---
	d) Convertible Securities	---	--	---
	e) Any other instrument that would entitle the holder toreceive shares in the TC	-.-	--	--
	Total	7,89,537	0.135	0.135
	GRAND TOTAL	30,43,15,471	51.936	51.936

Part - 8**

N ameo fthe T arge tC ompany: AUROBINDO PHARMA LIMITED

51.	Name(s) of the person and Persons Acting in	Whether the person belongs
No.	Concert (PAC) with the person	to Promoterl Promoter group
1	MR. P.V RAMPRASAD REDDY	Promoter
2	MR. K NITYANANDA REDDY	Promoter
3	RPR SONS ADVISORS PVT.L TO	Promoter Group
	MRS.P.SUNEELA RANI
	(Jointly holding)
4	MRS. K RAJESWARI	Promoter Group
5	MRS. K KIRTHI REDDY	Promoter Group
6	MRS. K SPOORTHI	Promoter Group
7	MRS.P. NEHA REDDY	Promoter Group
8	MR.K. PRASAD REDDY	Promoter Group
9	MR. K SURYAPRAKASH REDDY	Promoter Group
10	DR. M SIVAKUMARAN	Promoter Group
11	AXIS CLiNICALS LIMITED	Promoter Group
	TRIDENT CHEMPHAR LTD
	RPR SONS ADVISORS PVT.L TO
	(Jointly holding)
12	MR. M SUMANTH KUMAR REDDY	Promoter Group
13	AXIS CLiNICALS LIMITED	Promoter Group
14	TRIDENT CHEMPHAR LIMITED	Promoter Group

~. ~- q

K. NITmANANM REDDY AUTHORISED SIGNATORY (PROMOTER GROUP-AUROBINDO PHARMA LIMITED)

Place: Hyderabad Date: April 6, 2021

Note:

1. In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.

(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

(**) Part-8 shall be disclosed to the Stock Exchanges but shall not be disseminated.